Our present findings indicate significantly shorter activated partial thromboplastin time (APTT) in the T2DM group compared to control subjects, but without any significant differences in thrombin (TT) or prothrombin (PT) time. This evidence concerns the gene F2 and type 2 diabetes mellitus.